Fragile X syndrome

被引:278
作者
Garber, Kathryn B. [1 ]
Visootsak, Jeannie [1 ]
Warren, Stephen T. [1 ]
机构
[1] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA
关键词
fragile X syndrome; FMR1; permutation; full mutation; autism;
D O I
10.1038/ejhg.2008.61
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fragile X syndrome, an X-linked dominant disorder with reduced penetrance, is associated with intellectual and emotional disabilities ranging from learning problems to mental retardation, and mood instability to autism. It is most often caused by the transcriptional silencing of the FMR1 gene, due to an expansion of a CGG repeat found in the 5'-untranslated region. The FMR1 gene product, FMRP, is a selective RNA-binding protein that negatively regulates local protein synthesis in neuronal dendrites. In its absence, the transcripts normally regulated by FMRP are over translated. The resulting over abundance of certain proteins results in reduced synaptic strength due to AMPA receptor trafficking abnormalities that lead, at least in part, to the fragile X phenotype.
引用
收藏
页码:666 / 672
页数:7
相关论文
共 54 条
[1]  
Allingham-Hawkins SJ, 1999, AM J MED GENET, V83, P322, DOI 10.1002/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO
[2]  
2-B
[3]  
BAILEY DB, 1999, MMWR-MORBID MORTAL W, V51, P740
[4]   The mGIuR theory of fragile X mental retardation [J].
Bear, MF ;
Huber, KM ;
Warren, ST .
TRENDS IN NEUROSCIENCES, 2004, 27 (07) :370-377
[5]   Psychopharmacology in fragile X syndrome - Present and future [J].
Berry-Kravis, E ;
Potanos, K .
MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS, 2004, 10 (01) :42-48
[6]   Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: A controlled trial [J].
Berry-Kravis, Elizabeth ;
Krause, Sue Ellen ;
Block, Sandra S. ;
Guter, Steve ;
Wuu, Joanne ;
Leurgans, Sue ;
Decle, Penelope ;
Potanos, Kristina ;
Cook, Edwin ;
Salt, Jeff ;
Maino, Dominick ;
Weinberg, Dahlia ;
Lara, Rebecca ;
Jardini, Tristan ;
Cogswell, Jennifer ;
Johnson, Steven A. ;
Hagerman, Randi .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2006, 16 (05) :525-540
[7]   RAPID FRAGILE-X CARRIER SCREENING AND PRENATAL-DIAGNOSIS USING A NONRADIOACTIVE PCR TEST [J].
BROWN, WT ;
HOUCK, GE ;
JEZIOROWSKA, A ;
LEVINSON, FN ;
DING, XH ;
DOBKIN, C ;
ZHONG, N ;
HENDERSON, J ;
BROOKS, SS ;
JENKINS, EC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (13) :1569-1575
[8]   FRAGILE-X AND AUTISM - A MULTICENTER SURVEY [J].
BROWN, WT ;
JENKINS, EC ;
COHEN, IL ;
FISCH, GS ;
WOLFSCHEIN, EG ;
GROSS, A ;
WATERHOUSE, L ;
FEIN, D ;
MASONBROTHERS, A ;
RITVO, E ;
RUTTENBERG, BA ;
BENTLEY, W ;
CASTELLS, S .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1986, 23 (1-2) :341-352
[9]   FMR1 and the fragile X syndrome:: Human genome epidemiology review [J].
Crawford, DC ;
Acuña, JM ;
Sherman, SL .
GENETICS IN MEDICINE, 2001, 3 (05) :359-371
[10]  
deVries BBA, 1996, AM J HUM GENET, V58, P1025